Partner Adam Schoen Named a 2025 ‘Go To Intellectual Property Lawyer’ by Massachusetts Lawyers Weekly

Partner Adam Schoen has been recognized by Massachusetts Lawyers Weekly as a Go To Intellectual Property Lawyer for 2025. The Go To Lawyer list showcases leaders in the Massachusetts legal community across practice areas.

Schoen was selected for his leadership in IP within life sciences and work with venture funds and their associated portfolio companies. He has more than two decades of experience in the life sciences industry and experience advising life sciences and medical device funds, companies, and academic institutions. Schoen has built a strong reputation for helping clients build, grow, invest in, buy, and sell companies of all sizes globally.

In an August 18 profile, Schoen discussed the most rewarding part of his work.

"Helping clients develop and protect robust portfolios that ultimately attracted investment or enabled exit events, such as Kate Therapeutics in its $1.1 billion sale to Novartis, Aliada Therapeutics in its sale to AbbVie, and Navigator Medicines following its $100 million Series A financing round."

Read the full profile here.